The novel role of circular RNA ST3GAL6 on blocking gastric cancer malignant behaviours through autophagy regulated by the FOXP2/MET/mTOR axis.
Penghui XuXing ZhangJiacheng CaoJing YangZetian ChenWeizhi WangSen WangLu ZhangLi XieLang FangYiwen XiaZhe XuanJialun LvHao XuZe-Kuan XuPublished in: Clinical and translational medicine (2022)
Gastric cancer (GC) ranks third in mortality among all cancers worldwide. Circular RNAs (circRNAs) play an important role in the occurrence and development of gastric cancer. Forkhead box P2 (FOXP2), as a transcription factor, is closely associated with the development of many types of tumours. However, the regulatory network between FOXP2 and circRNAs remains to be explored. In our study, circST3GAL6 was significantly downregulated in GC and was associated with poor prognosis in GC patients. Overexpression of circST3GAL6 inhibited the malignant behaviours of GC cells, which was mediated by inducing apoptosis and autophagy. In addition, we demonstrated that circST3GAL6 regulated FOXP2 through the mir-300 sponge. We further found that FOXP2 inhibited MET Proto-Oncogene (MET), which was the initiating factor that regulated the classic AKT/mTOR pathway of autophagy. In conclusion, our results suggested that circST3GAL6 played a tumour suppressive role in gastric cancer through miR-300/FOXP2 axis and regulated apoptosis and autophagy through FOXP2-mediated transcriptional inhibition of the MET axis, which may become a potential target for GC therapy.
Keyphrases
- transcription factor
- regulatory t cells
- endoplasmic reticulum stress
- cell death
- cell proliferation
- poor prognosis
- oxidative stress
- cell cycle arrest
- long non coding rna
- induced apoptosis
- signaling pathway
- tyrosine kinase
- dna binding
- gas chromatography
- end stage renal disease
- newly diagnosed
- long noncoding rna
- gene expression
- type diabetes
- cardiovascular events
- chronic kidney disease
- cardiovascular disease
- ejection fraction
- risk factors
- immune response
- liquid chromatography
- high resolution
- genome wide identification
- replacement therapy
- smoking cessation
- network analysis
- patient reported
- binding protein